Treatment of Clinical T2N0M0 Esophageal Cancer

Annals of Surgical Oncology

Volumn 21, Issue 12, 2014, Pages 3739-3743

  Hardacker, Thomas J ^a   Ceppa, DuyKhanh ^a   Okereke, Ikenna ^a   Rieger, Karen M ^a   Jalal, Shadia I ^a   LeBlanc, Julia K ^a   DeWitt, John M ^a   Kesler, Kenneth A ^a   Birdas, Thomas J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADJUVANT THERAPY; ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; LONG TERM SURVIVAL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODAL CHEMOTHERAPY; OUTCOME ASSESSMENT; SURGICAL MORTALITY; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; CARCINOMA, SQUAMOUS CELL; COMPARATIVE STUDY; ESOPHAGEAL NEOPLASMS; LYMPH NODE DISSECTION; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RADIOTHERAPY; SURVIVAL RATE;

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ENDOSONOGRAPHY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY; SURVIVAL RATE;

EID: 84918820529     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3929-6     Document Type: Article

References (13)

1. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142–6.
2. Zuccaro G Jr, Rice TW, Vargo JJ, et al. Endoscopic ultrasound errors in esophageal cancer. Am J Gasteroenterol. 2005;100:601–6.
3. Rice TW, Mason DP, Murthy SC, et al. T2N0M0 esophageal cancer. J Thorac Cardiovasc Surg. 2007;133:317–24.
4. Zhang JQ, Hooker CM, Brock MV, et al. Neoadjuvant chemoradiation therapy is beneficial for clinical stage T2 N0 esophageal cancer patients due to inaccurate preoperative staging. Ann Thorac Surg. 2012;93:429–35.
5. Crabtree TD, Kosinski AS, Puri V, et al. Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database. Ann Thorac Surg. 2013;96:382–90.
6. Kountourakis P, Correa AM, Hofstetter WL, et al. Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas MD Anderson Cancer Center experience. Cancer. 2011;117:925–30.
7. Kesler KA, Helft PR, Werner EA, et al. A retrospective analysis of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation therapy followed by surgery or surgery alone. Ann Thorac Surg. 2005;79:1116–21.
8. Chandawarkar RY, Kakegawa T, Fujita H, Yamana H, Toh Y, Fujitoh H. Endosonography for preoperative staging of specific nodal groups associated with esophageal cancer. World J Surg. 1996;20:700–2.
9. DeWitt J, Kesler K, Brooks JA, et al. Endoscopic ultrasound for esophageal and gastroesophageal junction cancer: impact of increased use of primary neoadjuvant therapy on preoperative locoregional staging accuracy. Dis Esophagus. 2005;18:21–7.
10. Campbell NP, Villaflor VM. Neoadjuvant treatment of esophageal cancer. World J Gastroenterol. 2010;16:3793–803.
11. Rohatgi A, Naji S, Hamouda A, et al.: Effect of understaging of early oesophageal cancers on treatment. J Clin Oncol. 2009;27(suppl):15572.
12. Crabtree TD, Yacoub WN, Puri V, et al. Endoscopic ultrasound for early stage esophageal adenocarcinoma: implications for staging and survival. Ann Thorac Surg. 2011;91:1509–15.
13. Stiles BM, Mirza F, Coppolino A, et al. Clinical T2–T3N0M0 esophageal cancer: the risk of node positive disease. Ann Thorac Surg. 2011;92:491–6.